397 related articles for article (PubMed ID: 21192804)
21. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
Myers KV; Amend SR; Pienta KJ
Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
[TBL] [Abstract][Full Text] [Related]
22. MafB enhances efferocytosis in RAW264.7 macrophages by regulating Axl expression.
Sato M; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Nemoto T; Sato K; Nakano H; Abe S; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Kubota I
Immunobiology; 2018 Jan; 223(1):94-100. PubMed ID: 29030012
[TBL] [Abstract][Full Text] [Related]
23. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
24. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.
Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B
Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216
[TBL] [Abstract][Full Text] [Related]
25. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
Kayashima Y; Makhanova N; Maeda N
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
[TBL] [Abstract][Full Text] [Related]
26. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
[TBL] [Abstract][Full Text] [Related]
28. Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury.
Brosius Lutz A; Chung WS; Sloan SA; Carson GA; Zhou L; Lovelett E; Posada S; Zuchero JB; Barres BA
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8072-E8080. PubMed ID: 28874532
[TBL] [Abstract][Full Text] [Related]
29. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H
Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187
[TBL] [Abstract][Full Text] [Related]
30. Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage.
Chang CF; Goods BA; Askenase MH; Hammond MD; Renfroe SC; Steinschneider AF; Landreneau MJ; Ai Y; Beatty HE; da Costa LHA; Mack M; Sheth KN; Greer DM; Huttner A; Coman D; Hyder F; Ghosh S; Rothlin CV; Love JC; Sansing LH
J Clin Invest; 2018 Feb; 128(2):607-624. PubMed ID: 29251628
[TBL] [Abstract][Full Text] [Related]
31. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.
Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008
[TBL] [Abstract][Full Text] [Related]
32. Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction.
DeBerge M; Glinton K; Subramanian M; Wilsbacher LD; Rothlin CV; Tabas I; Thorp EB
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33529176
[TBL] [Abstract][Full Text] [Related]
33. Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.
Kimani SG; Kumar S; Davra V; Chang YJ; Kasikara C; Geng K; Tsou WI; Wang S; Hoque M; Boháč A; Lewis-Antes A; De Lorenzo MS; Kotenko SV; Birge RB
Cell Commun Signal; 2016 Sep; 14(1):19. PubMed ID: 27595981
[TBL] [Abstract][Full Text] [Related]
34. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
[TBL] [Abstract][Full Text] [Related]
35. Cell-Corpse Clearance after Lung Damage: The Essential Role of MerTK-mediated Alveolar Macrophage Efferocytosis.
Haczku A
Am J Respir Cell Mol Biol; 2024 Jun; 70(6):433-434. PubMed ID: 38502903
[No Abstract] [Full Text] [Related]
36. An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo.
Subramanian M; Hayes CD; Thome JJ; Thorp E; Matsushima GK; Herz J; Farber DL; Liu K; Lakshmana M; Tabas I
J Clin Invest; 2014 Mar; 124(3):1296-308. PubMed ID: 24509082
[TBL] [Abstract][Full Text] [Related]
37. Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling.
Bagci H; Laurin M; Huber J; Muller WJ; Côté JF
Cell Death Dis; 2014 Aug; 5(8):e1375. PubMed ID: 25118935
[TBL] [Abstract][Full Text] [Related]
38. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ
PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822
[TBL] [Abstract][Full Text] [Related]
39. p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.
Yallowitz AR; Alexandrova EM; Talos F; Xu S; Marchenko ND; Moll UM
Cell Death Differ; 2014 Apr; 21(4):645-54. PubMed ID: 24440910
[TBL] [Abstract][Full Text] [Related]
40. Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment.
Zhou L; Matsushima GK
Int Rev Cell Mol Biol; 2021; 361():165-210. PubMed ID: 34074493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]